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Abstract: Background and aims pH-sensing ovarian cancer G-protein coupled receptor-1 (OGR1/GPR68)
is regulated by key inflammatory cytokines. Patients suffering from inflammatory bowel diseases (IBD)
express increased mucosal levels of OGR1 compared to non-IBD controls. pH-sensing may be relevant
for progression of fibrosis, as extra-cellular acidification leads to fibroblast activation and extracellular
matrix remodeling. We aimed to determine OGR1 expression in fibrotic lesions in the intestine of Crohn’s
disease (CD) patients, and the effect of Ogr1 deficiency in fibrogenesis. Methods Human fibrotic and
non-fibrotic terminal ileum was obtained from CD patients undergoing ileocecal resection due to stenosis.
Gene expression of fibrosis markers and pH-sensing receptors was analyzed. For the initiation of fibro-
sis in vivo, spontaneous colitis by Il10-/-, dextran sodium sulfate (DSS)-induced chronic colitis and the
heterotopic intestinal transplantation model were used. Results Increased expression of fibrosis markers
was accompanied by an increase of OGR1 (2.71±0.69 vs. 1.18±0.03,P=0.016) in fibrosis-affected hu-
man terminal ileum, compared to the non-fibrotic resection margin. Positive correlation between OGR1
expression and pro-fibrotic cytokines (TGFB1 and CTGF) and pro-collagens was observed. The hetero-
topic animal model for intestinal fibrosis transplanted with terminal ileum from Ogr1-/- mice showed a
decrease in mRNA expression of fibrosis markers as well as a decrease in collagen layer thickness and
hydroxyproline compared to grafts from wildtype mice. Conclusions OGR1 expression correlates with
increased expression levels of pro-fibrotic genes and collagen deposition. Ogr1 deficiency is associated
with a decrease in fibrosis formation. Targeting OGR1 may be a potential new treatment option for
IBD-associated fibrosis.
DOI: https://doi.org/10.1093/ecco-jcc/jjy118
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-157615
Journal Article
Accepted Version
Originally published at:
Hutter, Senta; van Haaften, Wouter T; Hünerwadel, Anouk; Baebler, Katharina; Herfarth, Neel; Raselli,
Tina; Mamie, Céline; Misselwitz, Benjamin; Rogler, Gerhard; Weder, Bruce; Dijkstra, Gerard; Meier,
Chantal Florence; de Vallière, Cheryl; Weber, Achim; Imenez Silva, Pedro H; Wagner, Carsten A; Frey-
Wagner, Isabelle; Ruiz, Pedro A; Hausmann, Martin (2018). Intestinal activation of pH-sensing receptor
OGR1 (GPR68) contributes to fibrogenesis. Journal of Crohn’s Colitis, 12(11):1348-1358.
DOI: https://doi.org/10.1093/ecco-jcc/jjy118
2
S Hutter et al.   Decreased fibrogenesis upon OGR1 depletion       1 
 
TITLE PAGE 1 
Intestinal acidification sensed by pH-sensing receptor OGR1 (GPR68) 2 
contributes to fibrogenesis 3 
Short title: Decreased fibrogenesis upon OGR1 depletion 4 
 5 
Senta Hutter1#, Wouter Tobias van Haaften2,3#, Anouk Hünerwadel1, 6 
Katharina Baebler1, Neel Herfarth1, Tina Raselli1, Céline Mamie1, Benjamin 7 
Misselwitz1, Gerhard Rogler1,4, Bruce Weder1, Gerard Dijkstra2, Chantal 8 
Florence Meier1, Cheryl de Vallière1, Achim Weber5, Carsten A. Wagner4, 9 
Isabelle Frey-Wagner1, Pedro A. Ruiz1, Martin Hausmann1 10 
 11 
1 Department of Gastroenterology and Hepatology, University Hospital Zürich, 12 
Zürich, Switzerland 13 
2 Department of Gastroenterology and Hepatology, University Medical Center 14 
Groningen, University of Groningen, Groningen, the Netherlands 15 
3 Department of Pharmaceutical Technology and Biopharmacy, Groningen 16 
Research Institute of Pharmacy, University of Groningen, Groningen, The 17 
Netherlands 18 
4 Institute of Physiology, University of Zürich, Zürich, Switzerland 19 
5 Department of Pathology and Molecular Pathology, University Hospital Zürich, 20 
Zürich, Switzerland 21 
# Equal contribution 22 
 23 
Corresponding author: 24 
Martin Hausmann PhD 25 
S Hutter et al.   Decreased fibrogenesis upon OGR1 depletion       2 
___________________________________________________________________________ 
 
Department of Gastroenterology and Hepatology 26 
University Hospital Zürich 27 
8091 Zurich, CH-Switzerland 28 
Mail:  martin.hausmann@usz.ch 29 
Tel.: +41 44 255 9916, Fax: +41 44 255 9496 30 
 31 
Word count (abstract, main body, references): 5694 32 
 33 
Abbreviations: 34 
ACTA2, α-smooth muscle actin; ASMC, airway smooth muscle cells; ACTB, 35 
beta-actin; CD, Crohn’s disease; CTGF, connective tissue growth factor; 36 
ECM, extracellular matrix; GAPDH, glyceraldehyde-3-phosphate 37 
dehydrogenase; OGR1/GPR68, G-protein coupled receptor 1; GPR, G-38 
protein-coupled receptor; HSP90, heat shock protein 90; HPRT, hypoxanthine 39 
phosphoribosyltransferase 1; HYP, 4-Hydroxyproline; IBD, inflammatory 40 
bowel diseases; IL, interleukin; MSC, mesenchymal stem cell; mRNA, 41 
messenger RNA; COL1A1, pro-collagen type I alpha 1; COL3A1,pro-collagen 42 
type III alpha 1; RT-qPCR, quantitative reverse-transcription polymerase 43 
chain reaction; TDAG8/GPR65, T cell death-associated gene 8; TGF-β1, 44 
Transforming growth factor β1; TNF, tumor necrosis factor; UC, ulcerative 45 
colitis; VIM, vimentin 46 
 47 
No external writing assistance was provided in drafting this manuscript 48 
S Hutter et al.   Decreased fibrogenesis upon OGR1 depletion       3 
___________________________________________________________________________ 
 
The manuscript, including related data, figures and tables has not been 49 
previously published and that the manuscript is not under consideration 50 
elsewhere 51 
 52 
Authors contributions 53 
- study concept; G Rogler 54 
- acquisition of data and drafting of the manuscript; S Hutter, WT van 55 
Haaften, M Hausmann  56 
- acquisition of data: A Hünerwadel, C Mamie, B Weder, CF Meier, K 57 
Baebler, N Herfarth 58 
- critical revision of the manuscript; B Misselwitz, G Rogler, G Dijkstra, C 59 
de Vallière, A Weber, C Wagner, I Frey-Wagner, PA Ruiz, M Hausmann 60 
- technical support; C Mamie, T Raselli 61 
- all authors approved the final submitted version of the manuscript 62 
63 
S Hutter et al.   Decreased fibrogenesis upon OGR1 depletion       4 
___________________________________________________________________________ 
 
ABSTRACT 64 
Background and aims: pH-sensing ovarian cancer G-protein coupled 65 
receptor-1 (OGR1/GPR68) is regulated by key inflammatory cytokines. Patients 66 
suffering from inflammatory bowel diseases (IBD) express increased mucosal 67 
levels of OGR1 in the mucosa compared to non-IBD controls. pH-sensing may 68 
be relevant for progression of fibrosis, as extra-cellular acidification leads to 69 
fibroblast activation and extracellular matrix remodeling. We aimed to 70 
determine OGR1 expression in fibrotic lesions in the intestine of Crohn’s 71 
disease (CD) patients, and the effect of Ogr1 deficiency in fibrogenesis.  72 
Methods: Human fibrotic and non-fibrotic terminal ileum was obtained from CD 73 
patients undergoing ileocecal resection due to stenosis. Gene expression of 74 
fibrosis markers and pH-sensing receptors was analyzed. The in vivo murine 75 
heterotopic transplantation model of intestinal fibrosis was used. Collagen layer 76 
thickness and hydroxyproline content was determined. 77 
Results: Increased expression of fibrosis markers was accompanied by an 78 
increase of OGR1 (2.71±0.69 vs. 1.18±0.03, P=0.016) in fibrosis-affected 79 
human terminal ileum, compared to the non-fibrotic resection margin. Positive 80 
correlation between OGR1 expression and pro-fibrotic cytokines (TGFB1 and 81 
CTGF) or pro-collagens was observed. The heterotopic animal model for 82 
intestinal fibrosis transplanted with terminal ileum from Ogr1-/- mice showed a 83 
significant decrease in mRNA expression of fibrosis markers as well as a 84 
decrease in collagen layer thickness and hydroxyproline compared to grafts 85 
from wildtype mice.  86 
Conclusions: OGR1 expression correlates with the expression of pro-fibrotic 87 
genes and increased levels of collagen deposition. Ogr1 deficiency is 88 
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associated with a decrease in fibrosis formation. Targeting OGR1 may be a 89 
potential new treatment option for IBD-associated fibrosis. 90 
 91 
Keywords: Fibrosis, Crohn’s disease, IBD models  92 
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INTRODUCTION 93 
Recent studies have shown a link between inflammatory bowel diseases (IBD) 94 
and the family of pH-sensing G-protein-coupled receptors (GPRs).1-5 Three 95 
GPRs from the GPR4-subfamily were identified as sentinels for proton 96 
concentration, as they enable cells to sense the surrounding pH and to respond 97 
to it.6, 7 This GPR4-subfamily of receptors includes GPR4, ovarian cancer GPR 98 
1 (OGR1/GPR68) and T cell death-associated gene 8 (TDAG8/GPR65). These 99 
receptors sense extracellular protons through histidine residues located in the 100 
extracellular region of the receptors, resulting in signaling pathway activation 101 
and the modification of a variety of cell functions.6, 7 GPRs are also regulated 102 
by key inflammatory cytokines.8-10 The proton-sensing pH receptors TDAG8, 103 
OGR1 and GPR4 are inactive or only slightly active in an alkaline environment 104 
(pH 7.6-7.8), but become highly activated in acidic environments (pH 6.8).7, 11-105 
13 GPR132 structurally belongs to the subclade but is not considered anymore 106 
as a true member of this family.  107 
IBD affects approximately one in a hundred and fifty people in the industrialized 108 
world. It comprises two main conditions, namely ulcerative colitis (UC) and 109 
Crohn’s disease (CD), and is characterized by a chronic inflammation of the 110 
intestinal wall. Severe and persistent mucosal tissue damage is one of the main 111 
features of IBD. Tissue injury is associated with an acidic pH shift, as 112 
inflammation increases local proton concentration and lactate production. This 113 
induces subsequent pro-inflammatory cytokine production, such as tumor 114 
necrosis factor (TNF).14-16 An acidic environment is not only the result of 115 
inflammation but also affects the degree and outcome of inflammation.13, 17, 18 116 
A disturbed pH homeostasis due to acidification of the intestinal environment 117 
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leads to the activation of OGR1.19 Recent work demonstrates that patients 118 
suffering from IBD express increased levels of OGR1 in the mucosa compared 119 
to non-IBD controls.3, 4 The expression of OGR1 is also increased in inflamed 120 
colonic mucosa compared to non-inflamed colonic mucosa in both CD and UC 121 
patients. Moreover, in mice lacking Ogr1, inflammation was attenuated.4 122 
Wound healing after tissue damage requires an exquisite balance between 123 
multiple pro- and anti-fibrotic stimuli on extracellular matrix (ECM)-producing 124 
cells20-23 e.g. activated myofibroblasts.24 Matrix-producing cells are activated by 125 
paracrine signals, autocrine factors, damage-associated molecular patterns or 126 
pathogen-associated molecular patterns derived from microorganisms.25-28 127 
Transforming growth factor β1 (TGF-β1) is an important mediator of 128 
mesenchymal cell activation and its expression is increased in inflamed mucosa 129 
of IBD patients.29-32 Excessive tissue repair promotes fibrosis, impairs 130 
gastrointestinal function, and is a common clinical problem in patients with CD 131 
and UC.33 Increased tissue stiffness is associated with impaired absorption 132 
upon fibrogenesis.28 Fibrosis is increasingly recognized as an important cause 133 
of morbidity and mortality in patients with IBD. Intestinal fibrosis leads to 134 
stricture formation due to thickening of the intestinal wall in 30-50% of patients 135 
with CD,34, 35 and approximately 80% of these patients will require surgery.34 136 
Recently, it has been shown that fibrogenesis can also occur in long-standing 137 
(≥10 years) UC, leading to the formation of strictures.36  138 
In this study, we determined the expression of OGR1 in fibrotic lesions of 139 
human intestine in patients with CD compared to non-fibrotic control sections. 140 
Our results show that OGR1 expression correlates with the expression of pro-141 
fibrotic genes and the levels of collagen deposition. Furthermore, we studied 142 
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the role of Ogr1 in intestinal fibrogenesis in an animal model of fibrosis. Our 143 
results show that Ogr1 deficiency is associated with a decrease in fibrosis 144 
formation. Targeting OGR1 may be a potential new treatment option for IBD-145 
associated fibrosis.  146 
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MATERIALS AND METHODS 147 
Human tissue from patients with CD and non-fibrotic control patients 148 
Intestinal tissue from patients with CD was obtained from patients undergoing 149 
ileocecal resection because of stenosis in the terminal ileum (non-fibrosis 150 
affected resection margin and from the thickened fibrosis-affected region), and 151 
from patients undergoing right-sided hemicolectomy because of an 152 
adenocarcinoma (non-cancer affected ileal resection margin, Supplementary 153 
table 1). Just after resection, samples for RNA were fixed in Tissue-Tek® 154 
(O.C.T. Compound, Sakura® Finetek) in the operation room and frozen in 155 
isopentane on dry ice. Samples were stored at -80°C until further use. Intestinal 156 
epithelial crypts were isolated as previously described.37 157 
 158 
Animals 159 
All animal experiments were performed according to the ARRIVE criteria for in 160 
vivo experiments. The generation, breeding and genotyping of male C57BL/6J-161 
Ogr1<tm1> (Ogr1-/-) has been described previously.4, 19 The animals were co-162 
housed to minimize potential effects of different microbiota. Male C57BL/6 163 
wildtype (WT) donor mice were obtained from Jackson Laboratories. 12 female 164 
B6-Tg(UBC-GFP)30Scha/J (GFP) recipient mice were bred locally. Mice used 165 
for the experiment weighed 19-23 g and were 12-16 weeks old when the 166 
experiment was started. The animals received standard laboratory mouse food 167 
and water ad libitum. They were housed under specific pathogen-free 168 
conditions in a regular day-night cycle in individually ventilated cages with 169 
standard bedding and cage enrichment. Surgeries were always performed 170 
during the light cycle. 171 
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Ethical considerations 172 
Patients gave written informed consent for anonymous use of patient data and 173 
resected parts of human intestine according to the code of conduct for 174 
responsible use of surgical left-over material (See: Code goed gebruik voor 175 
gecodeerd lichaamsmateriaal, Research Code University Medical Center 176 
Groningen, (www.rug.nl/umcg/research/documents/research-code-info-umcg-177 
nl.pdf). Further, we retrieved permission to isolate different mucosal cells from 178 
intestinal samples, and to use data from patients from a cohort study of Swiss 179 
residents diagnosed with IBD, approved by the local ethical committee of the 180 
Kanton Zurich (EK-1316). The animal experiment protocol was approved by 181 
the Veterinary Authority of the Kanton of Zurich (registration number 182 
ZH242/2016). 183 
 184 
Heterotopic intestinal transplant model 185 
The heterotopic mouse intestinal transplant model is an adaption of the 186 
heterotopic transplantation model of intestinal fibrosis in rats, which has been 187 
previously described in detail.38 Briefly, donor small bowel resections were 188 
extracted and transplanted subcutaneously into the neck of recipient animals. 189 
Donor small bowel proximal to the caecum was excised and flushed with 5 ml 190 
of 0.9 % NaCl to remove stool, and divided into 10 mm parts. A small bowel 191 
resection was implanted into a subcutaneous pouch, and a single dose of 192 
Cefazolin (Kefzol®, 1g diluted in 2.5ml distilled water) was administered 193 
intraperitoneally as infection prophylaxis. Intestinal grafts were explanted 7 194 
days after transplantation. Donor and recipient mice were euthanized by 195 
cervical dislocation. After explantation, each graft was divided into three equal 196 
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segments. One segment was fixed in 4 % formalin for histopathological 197 
assessment. The other two segments were snap frozen in liquid nitrogen and 198 
stored at -80° C until RNA extraction or for determination of hydroxoproline 199 
(HYP) content. 200 
 201 
RNA isolation and RT-qPCR from Tissue-Tek embedded samples and 202 
from mouse samples 203 
For human samples, ten 10 μM thick Tissue-Tek sections, containing full cross 204 
sections of the intestinal wall were cut using a cryostat. Sections were dissolved 205 
and homogenized in TRIzol (Invitrogen, Life Technologies) and total RNA was 206 
isolated according to the manufacturer’s protocol. To avoid genomic DNA 207 
contamination, samples were treated with DNase I, Amp Grade (Invitrogen, Life 208 
Technologies) according to the manufacturer’s protocol. RNA isolation from 209 
mucosa, crypts and epithelial cells was performed as previously described.37 210 
RNA isolation of mice specimens was performed following the instructions of 211 
the RNeasy Mini Kit (Qiagen). RT-qPCR was performed using TaqMan gene 212 
expression assays (Supplementary table 2). mRNA expression is presented as 213 
2^-∆Ct, normalized to one of the samples in the control group. 214 
 215 
Sirius Red staining and collagen layer thickness measurement 216 
Fixed samples were processed in a benchtop tissue processor (Leica TP 1020), 217 
embedded and cut into 3µm sections. To visualize the collagen layer, the 218 
samples were stained with Sirius Red according to a standard protocol.39 Sirius 219 
red staining was examined using the Imager Z2 microscope (Zeiss) and the 220 
software AxioVision (Zeiss). The quantity of the by Sirius red stained collagen 221 
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was analyzed by ImageJ 1.47t (NIH, USA) using pictures taken under 222 
transmission light, as well as using a polarized light filter. To quantify the area 223 
with Sirius red stained collagen, cropped 100-fold magnification pictures 224 
(length:width ratio = 3:1) from at least eight representative areas comprising the 225 
collagen layer broad wise, for each single graft were taken. By setting 226 
thresholds to select the red collagen using ImageJ, the area being covered with 227 
collagen was quantified. Additionally, collagen layer thickness was measured 228 
in μm by a blinded investigator from at least eight places of representative areas 229 
at 100-fold magnification. 230 
 231 
4-Hydroxyproline (HYP) assay 232 
HYP (a major component of collagen) content was quantified from freshly 233 
isolated small bowel and grafts using a HYP assay (MAK008-1KT, Sigma-234 
Aldrich) according to the manufacturer’s protocol. In brief, tissues (10–30mg) 235 
were homogenized using gentleMACS Octo Dissociator (130-096-427, Miltenyl 236 
Biotec) and hydrolyzed in 12M HCl (10 µL/mg tissue). The hydrolysate was 237 
transferred in duplicates to a 96 well plate and dried at 60°C. Dried samples 238 
were incubated with 50µL of chloramine T/oxidation buffer mixture (3µL of the 239 
chloramine T concentrate and 47µL of the oxidation buffer) at room temperature 240 
for 5 minutes. 50µL of the diluted DMAB reagent (25µL 241 
dimethylaminobenzaldehyde, 25µL perchloric acid/isopropanol) was added 242 
and samples were incubated at 60 °C for 90 minutes for chromophore 243 
formation. Absorbance was measured at 560nm.  244 
 245 
Statistical analysis 246 
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GraphPad Prism software (v5.0) was used. All human RT-qPCR data was 247 
considered non-parametric. Therefore, non-paired analyses were performed 248 
using the Mann-Whitney U test, and paired analyses were performed using a 249 
Wilcoxon matched-pairs signed rank test. If more than 2 groups were 250 
compared, a Kruskal-Wallis with post-hoc Dunn’s test for multiple comparisons 251 
was performed. Correlation was determined using Spearman's rank correlation 252 
coefficient.  253 
Mouse data was considered parametric. Therefore, statistical analysis for 254 
collagen layer thickness was performed using one-way analysis of variance on 255 
ranks, all pairwise multiple comparison procedures (Student Newman-Keuls 256 
method). Statistical analysis for the HYP assay was performed using unpaired 257 
t-test. Statistical analysis for RT-qPCR in mice was performed using unpaired 258 
t-test or one-way analysis of variance on ranks, all pairwise multiple comparison 259 
procedures (Student Newman-Keuls method). 260 
Differences were considered significant at a P-value of <0.05* and highly 261 
significant at a P-value of <0.01** and P-value of <0.001***. In text and figures, 262 
averages ± standard error of the mean are presented.  263 
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RESULTS 264 
Expression of pH-sensing G-protein coupled receptors is increased in the 265 
fibrotic intestine in CD patients 266 
To elucidate the pathophysiological relevance of pH-sensing receptors, we 267 
determined whether the expression of GPRs is increased in fibrosis affected 268 
terminal ileum vs. non-fibrotic terminal ileum from patients with CD. mRNA 269 
expression of fibrosis markers COL1A1 (108.46±60.57 vs. 6.70±2.02, *P<0.05), 270 
COL3A1 (35.68±17.66 vs. 3.14±0.73, *P<0.05), ACTA2 (13.91±4.10 vs. 271 
5.12±2.20, *P<0.05) and TGFB1 (4.72±1.18 vs. 1.52±0.34, **P<0.01) was 272 
significantly increased in the fibrosis-affected area, compared to the non-273 
fibrosis affected resection margin (Figure 1A). The increase of fibrosis markers 274 
was accompanied by a significant increase in the mRNA expression of OGR1 275 
(GPR68, 2.71±0.69 vs. 1.18±0.03, *P<0.05), TDAG8 (GPR65, 4.14±1.01 vs. 276 
1.59±0.32, **P<0.01) and GPR4 (9.94±1.05 vs. 3.23±0.76, *P<0.05) in the 277 
fibrosis-affected terminal ileum (Figure 1B). For GPR132 (1.28±0.38 vs. 278 
0.64±0.12, P=0.08), no difference between fibrosis and non-fibrosis affected 279 
tissue was observed. To verify that the (unaffected) resection margins were free 280 
of fibrosis, we compared these samples to non-cancer affected terminal ileum 281 
resection margins from resections due to adenocarcinoma. Here, no 282 
differences were observed in mRNA expression of COL1A1 (6.70±2.01 vs. 283 
2.07±0.50, P=0.57), COL3A1 (3.14±0.72 vs. 1.26±0.34, P=0.21), ACTA2 284 
(5.12±2.20 vs. 2.72±0.40, P>0.99) and TGFB1 (1.52±0.44 vs. 1.06±0.42, 285 
P=0.68, Supplementary figure 1). Also, no differences were observed between 286 
non-cancer affected control tissue and the non-fibrosis affected resection 287 
margin from patients with CD in OGR1 (GPR68, 1.18±0.03 vs. 0.93±0.16, 288 
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P=0.57), TDAG8 (GPR65, 1.59±0.31 vs. 1.41±0.24, P=0.81), GPR4 (3.24±0.76 289 
vs. 3.73±1.41, P=0.57) and GPR132 (0.64±0.12 vs. 0.91±0.28, P=0.46, 290 
Supplementary figure 1, Supplementary table 2). Furthermore, a correlation 291 
between GPR68 (OGR1) vs. COL3A1 (R2 0.791, ***P<0.001) and TGFB1 (R2 292 
0.850, ***P<0.001) was found (Figure 2, Table 1). This confirms our hypothesis 293 
that expression of OGR1 is associated with fibrogenesis in human terminal 294 
ileum, affected by CD. 295 
To further examine which cells of the intestinal mucosa express the different 296 
pH-sensing receptors, mRNA expression for GPR68 (OGR1), GPR65 297 
(TDAG8), GPR4, and GPR132 was determined in RNA isolated from epithelial 298 
cells and mucosa from the same patient sample (Supplementary figure 2). 299 
mRNA expression of the pH-sensing GPRs was increased in whole mucosal 300 
tissue compared to isolated crypts for OGR1 (GPR68, 15.715.0 (n=13) vs. 301 
1.22.5 (n=8), **P<0.01) TDAG8 (GPR65, 30.642.1 (n=12) vs. 0.60.8 (n=8), 302 
**P<0.01), GPR132 (33.540.2 (n=13) vs. 1.33.0 (n=8), **P<0.01) and GPR4 303 
(80.390.1 (n=13) vs. 7.015.1 (n=8), **P<0.01, Supplementary figure 2). 304 
These results suggest that GPRs are mainly expressed by non-epithelial cells 305 
of the lamina propria of the human intestine such as fibroblasts or immune cells. 306 
 307 
Expression of pH-sensing receptors increases upon fibrogenesis in mice 308 
To determine the relevance of OGR1 in the development of fibrosis in murine 309 
tissue, Ogr1-/- and WT mice were used as donors and GFP expressing mice as 310 
recipients for isogeneic transplantation of the intestine in our heterotopic animal 311 
model for intestinal fibrosis. Body weight remained unchanged in both GFP 312 
recipient groups receiving either Ogr1-/- or WT grafts (data not shown). Grafts 313 
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were explanted 7 days after transplantation. From the 24 intestinal transplants, 314 
histologically evaluable tissue was obtained from all but 5 grafts. 315 
We hypothesized that increased expression of pH-sensing receptor OGR1 316 
plays a role in fibrosis formation in both human and murine intestine. Ogr1 317 
(Gpr68) mRNA expression in intestinal explants from WT donor mice at day 7 318 
after heterotopic transplantation was indeed significantly increased compared 319 
to WT donor grafts at day 0 before transplantation (5.711.03 (n=7) vs. 320 
1.920.72 (n=6) *P<0.05, Figure 3A). Furthermore, expression of Tdag8 321 
(Gpr65) was increased in the grafts at day 7 after heterotopic transplantation 322 
compared to freshly isolated small bowel in WT (4.061.04 (n=7) vs. 1.560.61 323 
(n=6), *P<0.05, Figure 3B). Next to that, Tdag8 (Gpr65) expression was 324 
decreased in the Ogr1-/- grafts explanted at day 7 compared to WT grafts 325 
(2.360.45 (n=11) vs. 4.061.04 (n=7), *P<0.05, Figure 3B).  326 
  327 
Expression of fibrosis markers is decreased in Ogr1-/- grafts upon 328 
induction of fibrosis 329 
Expression of fibrosis markers Vim, Col3a1, Tgfb1 and Ctgf was used to 330 
confirm the induction of fibrosis in this model and to study the effect of the lack 331 
of Ogr1. mRNA expression of Vim, a mesenchymal cell marker that can be used 332 
as a surrogate marker for the number of fibroblasts and the occurrence of 333 
endothelial-to-mesenchymal transition (EMT), was increased in WT grafts 7 334 
days after transplantation compared to the small bowel at day 0 (4.940.85 335 
(n=7) vs. 0.650.08 (n=6), ***P<0.001, Figure 4A). Furthermore, mRNA 336 
expression of Col3a1 (395.55201.0 (n=6) vs. 1.150.17 (n=6), *P<0.05), 337 
Tgfb1 (4.750.94 (n=7) vs. 0.980.17 (n=6), ***P<0.001), as well as Ctgf 338 
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(8.082.63 (n=7) vs. 1.700.64 (n=5), *P<0.05) was increased in grafts from 339 
WT donor mice 7 days after transplantation, showing that fibrosis was 340 
adequately induced in this model. mRNA expression of these four markers was 341 
not significantly increased in the Ogr1-/- grafts 7 days after heterotopic 342 
transplantation, compared to the small bowel at day 0 (Figure 4B-D). 343 
Most importantly, mRNA expression of Vim was decreased in grafts from Ogr1-344 
/- donor mice compared to grafts from WT mice at day 7 after heterotopic 345 
transplantation (2.800.41, (n=11) vs. 4.940.85 (n=7) **P<0.01, Figure 4A). 346 
The expression of Col3a1 mRNA was also decreased in Ogr1-/- grafts compared 347 
to WT mice at day 7 after transplantation (76.5528.88 (n=11) vs. 395.55201.0 348 
(n=6) *p<0.05, Figure 4B). Furthermore, mRNA expression of Tgfb1 and Ctgf, 349 
two mediators involved in activation of myofibroblasts, was significantly 350 
decreased in Ogr1-/- grafts at day 7 compared to WT grafts (Tgfb1: 2.330.47 351 
(n=11) vs. 4.750.94 (n=7) **P<0.01, Figure 4C. Ctgf: 3.120.59 (n=10) vs. 352 
8.082.63, (n=7) * P <0.05, Figure 4D). In summary, markers of fibrogenesis 353 
are significantly decreased in Ogr1-/- grafts compared to WT grafts in this 354 
heterotopic transplantation model for intestinal fibrosis. Fibrosis was 355 
successfully induced in this model in the WT grafts, whereas the expression of 356 
fibrosis markers remained unchanged in the Ogr1-/- grafts after heterotopic 357 
transplantation.  358 
 359 
Collagen deposition is decreased in Ogr1-/- grafts after induction of 360 
fibrosis 361 
Collagen layer thickness visualized by Sirius red staining was quantified under 362 
transmission light and under polarizing light before and after induction of fibrosis 363 
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(Figure 5). Collagen deposition was increased when using terminal ileum from 364 
WT mice as grafts (collagen layer thickness 12.440.51 µm (n=8) vs. 365 
8.720.68µm (n=6), ***P<0.001 under transmission light (Figure 5A), 366 
10.710.41µm (n=8) vs. 6.800.38 µm (n=6), ***P<0.001 under polarized light 367 
(Figure 5B)). Consistent with the increase in the mRNA expression of fibrosis 368 
markers, the collagen layer in the Ogr1-/- grafts was significantly increased 7 369 
days after heterotopic transplantation (collagen layer thickness 10.560.29 µm 370 
(n=11) vs. 7.930.47µm (n=6), **P<0.01 under transmission light (Figure 5A), 371 
8.710.39µm (n=11) vs. 5.910.31µm (n=6), *** P<0.001 under polarized light 372 
(Figure 5B)). Consistent with expression of the fibrosis mRNA, the collagen 373 
layer in harvested grafts at day 7 from Ogr1-/- mice was significantly thinner 374 
compared to the collagen layer in grafts from WT mice (10.56±0.29µm (n=11) 375 
vs. 12.44±0.51µm (n=8), ** P<0.01 for data obtained under transmission light 376 
(Figure 5A) and 8.71±0.39µm (n=11) vs. 10.71±0.41µm (n=8), *** P<0.001 for 377 
data obtained under polarized light microscopy (Figure 5B)).  378 
Collagen deposition in the grafts was furthermore quantified by image 379 
processing evaluation (color threshold) with ImageJ. Polarized light microscopy 380 
showed a significant decrease in collagen layer thickness in grafts from Ogr1-/- 381 
donor mice compared to grafts from WT donor mice (0.440.06 (n=11) vs. 382 
0.73±0.10 (n=8), arbitrary units, *P<0.05 (Figure 5C)). 383 
 384 
HYP content is significantly decreased in Ogr1-/- grafts 385 
Formation of HYP, an amino acid playing a key role in the stability of collagen, 386 
was determined in explanted grafts from mice at day 7 after heterotopic 387 
transplantation. HYP content was significantly decreased in grafts from Ogr1-/-388 
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donor mice compared to grafts of WT donor mice after heterotopic 389 
transplantation (0.120.02 (n=9) vs. 0.310.04 (n=4), ***P<0.001, Figure 6). 390 
This result confirms that collagen deposition, as well as collagen stability is 391 
reduced upon Ogr1 depletion in this murine model of intestinal fibrosis.  392 
 393 
Heat shock protein 90B1 (HSP90B1) decreases in Ogr1-/- grafts upon 394 
induction of fibrosis 395 
mRNA expression of the stress-associated gene HSP90B1 decreased 396 
significantly in grafts from Ogr1-/- donor mice at day 7 after heterotopic 397 
transplantation compared to day 0 (0.25±0.06 (n=11) vs. 1.04±0.21 (n=6) 398 
respectively, ***P<0.001, Supplementary figure 3). A trend towards a 399 
decreased HSP90B1 mRNA expression was observed in grafts from WT donor 400 
mice after transplantation compared to day 0.  401 
402 
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DISCUSSION 403 
In the present study we aimed to determine whether the pH-sensing receptor 404 
OGR1 plays a role in fibrosis in the terminal ileum. When analyzing the terminal 405 
ileum from patients with CD, we observed increased expression of the pH-406 
sensing GPRs OGR1 (GPR68), TDAG8 (GPR65) and GPR4 in the fibrosis-407 
affected area, compared to the non-fibrotic resection margin. We also found a 408 
positive correlation between the expression of markers involved in different 409 
phases of fibrosis, e.g. pro-fibrotic cytokines (TGFB1 and CTGF), a marker for 410 
activation of myofibroblasts (ACTA2) or pro-collagens (COL1A1 and COL3A1), 411 
and the expression of OGR1 (GPR68), TDAG8 (GPR65) and GPR4. Using a 412 
well-established in vivo murine model for intestinal fibrosis, we could confirm 413 
an increased expression of the pH-sensing receptors Ogr1 (Gpr68) and Tdag8 414 
(Gpr65) upon fibrogenesis. Furthermore, comparing heterotopic transplantation 415 
of terminal ileum from Ogr1-/- mice to transplantation of ileum from WT mice, we 416 
detected a significant decrease in the mRNA expression of fibrosis markers, as 417 
well as a decrease in collagen layer thickness and HYP in the Ogr1-/- grafts. 418 
These results indicate a role for the pH-sensing receptor OGR1 in fibrogenesis 419 
and stricture formation in CD, thereby providing a new target for therapeutic 420 
intervention. 421 
Intestinal fibrosis, which typically occurs in the terminal ileum of patients with 422 
CD, is triggered as a response to inflammatory processes, in which fibroblasts 423 
become activated. Activated myofibroblasts can deposit excessive amounts of 424 
ECM proteins as part of the wound healing process, thereby causing stricture 425 
formation.40 Fibrosis is the result of a disturbance in the balance between ECM 426 
formation and matrix metalloproteinase mediated degradation of ECM 427 
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proteins.41 It is widely accepted that intestinal inflammation is accompanied by 428 
tissue acidification due to the hypoxic environment and the excessive 429 
production and insufficient elimination of glycolytic metabolites e.g. lactic 430 
acid.42-44 Local acidification of the gut lumen as well as the gut mucosa during 431 
intestinal inflammation has been described. This indicates that luminal and 432 
tissue pH is decreased during active and longstanding IBD, which could 433 
activate down-stream signaling by pH-sensing receptors. The heterotopic 434 
transplantation of intestine resections under the skin induces a cellular, fibrosis-435 
inducing response from the graft as well as from the recipient.38 The graft is 436 
subjected to ischemia, which causes hypoxia and thereby anaerobic glycolysis 437 
and production of lactic acid.14-16 The ensuing decrease in pH may stimulate 438 
pH-sensing receptors such as OGR1. Furthermore, hypoxia induces the 439 
accumulation of hypoxia-inducible-factors (HIFs) and the release of pro-440 
inflammatory cytokines such as TNF and interleukin (IL) 6.45, 46 Only recently 441 
we found that the pH-sensing receptor OGR1 plays a role in IBD and that 442 
genetic deletion of Ogr1 partially prevents the development of colitis in the IL10 443 
deficient IBD mouse model.4 Moreover, the absence of Gpr4 ameliorates colitis 444 
in IBD animal models indicating an important regulatory role of this pH-sensing 445 
receptor in mucosal inflammation.5 Recently, we showed that expression of 446 
Ogr1, Tdag8, Il6 and Tnf is induced by the combination of hypoxia and 447 
extracellular acidosis in WT mouse peritoneal macrophages, but not in 448 
peritoneal macrophages from Ogr1-/- mice.46 Taken together, these studies 449 
indicate a pathophysiological role for pH-sensing receptors during the 450 
pathogenesis of mucosal inflammation, and provide a new link between tissue 451 
pH and immune responses.4  452 
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pH-sensing is not only relevant for the induction of inflammation, but also for 453 
the progression of fibrosis. Links between extra-cellular acidification and 454 
activation of fibroblasts, as well as ECM remodeling via GPRs have been 455 
described before. Zhu et al. demonstrated that differentiation of human bone-456 
marrow derived mesenchymal stem cells (MSCs) into cancer-associated 457 
fibroblasts via OGR1, occurs upon decreasing the extracellular pH to 7.0 in 458 
vitro. In this study, differentiation of MSCs into myofibroblasts was 459 
accompanied by increased protein expression of vimentin and alpha smooth 460 
muscle actin (αSMA).47 Furthermore, Li et al. show that migration of MCF-7 461 
cells (human breast adenocarcinoma cell line) over-expressing OGR1 is 462 
decreased (without exposing them to an acidic environment) and that this effect 463 
might be mediated via a GTPase Gα 12/13- Rho-Rac1 pathway.47 Differences 464 
in migratory function of intestinal fibroblasts isolated from stricturing and 465 
fistulating areas upon activation have been determined as factors in the 466 
mechanism of intestinal fibrosis as well. These mechanisms may contribute to 467 
the induction of fibrosis in this model, and explain the reduced fibrotic processes 468 
in grafts from Ogr1-/- mice.48  469 
OGR1 is also involved in tissue remodeling in severe asthma and irreversible 470 
airway obstruction.49 Airway remodeling results from increased expression of 471 
connective tissue or extracellular matrix proteins, airway smooth muscle cells 472 
(ASMC) hyperplasia, and hypertrophy,50 and is associated with airway 473 
acidification in asthma.51 The extracellular acidic pH-induced effects, like the 474 
induction of connective tissue growth factor expression, can be inhibited by 475 
inhibiting OGR1 with small interfering RNA and protein-specific inhibitors.49 476 
Further, Saxena et al. described that activation of OGR1 in human (ASMC) by 477 
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decreasing the extracellular pH to 6.8 causes contraction and cell stiffness, 478 
which was attenuated by OGR1 silencing.52  479 
There is evidence that intestinal fibrogenesis is self-perpetuating,53 and that 480 
once initiated, its progression might no longer depend on the presence of 481 
inflammation but could depend on persisting mucosal acidification.54 482 
Administration of anti-inflammatory agents effectively treats inflammatory 483 
flares, but may not prevent intestinal fibrosis.55, 56  484 
In conclusion, we provide the first evidence that OGR1 plays a role in intestinal 485 
fibrosis. Ogr1 deficiency leads to a significant decrease in mRNA expression of 486 
fibrosis markers, as well as an evident reduction in collagen deposition in our 487 
model for intestinal fibrosis. A decrease in HYP content after induction of 488 
fibrosis points to that also stabilization of collagen is impaired in grafts from 489 
Ogr1-/- compared to WT. The relevance of these findings is expanded by the 490 
positive correlation between the expression of GPRs and fibrosis markers in 491 
human ileum affected with fibrosis in CD patients. Increased expression of 492 
OGR1 triggered by inflammation-associated acidification, and subsequent 493 
cellular responses might perpetuate inflammation-induced fibrosis in IBD. The 494 
presence of OGR1 in human and murine intestinal tissue is associated with 495 
fibrosis making it a potential future target for treatment against IBD associated 496 
fibrogenesis. 497 
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FIGURE LEGENDS 681 
Figure 1: mRNA expression of fibrosis markers COL1A1, COL3A1, ACTA2, 682 
TGFB1 (A) and G-protein coupled receptors (GPRs) OGR1 (GPR68), TDAG8 683 
(GPR65), GPR4 and GPR132 (B) in fibrotic versus non-fibrotic terminal ileum 684 
of patients with CD (by Wilcoxon matched-pairs signed rank test). 685 
Figure 2: Positive correlation in mRNA expression between OGR1 (GPR68) 686 
vs. COL3A1 (R2 0.791, P<0.001) and TGFB1 (R2 0.791, P<0.01) (by 687 
Spearman's rank correlation coefficient). 688 
Figure 3: Ogr1 (Gpr68, A) (by unpaired t-test) and Tdag8 (Gpr65, B) (by 689 
ANOVA post-hoc Newman-Keuls multiple comparison test) mRNA expression 690 
is significantly increased in WT grafts explanted 7 days after heterotopic 691 
transplantation. Tdag8 (Gpr65) mRNA expression is significantly decreased in 692 
grafts from Ogr1-/- donor mice at day 7 compared to grafts from WT donor mice 693 
at day 7.  694 
Figure 4: Vim (A), Col3a1 (B), Tgfb1 (C) and Ctgf (D) mRNA expression is 695 
significantly decreased in grafts from Ogr1-/- mice 7 days after heterotopic 696 
transplantation compared to WT grafts (ANOVA post-hoc Newman-Keuls 697 
multiple comparison test). 698 
Figure 5: Collagen quantity and collagen layer thickness are significantly 699 
decreased in grafts from Ogr1-/- donor mice compared to WT donor mice 7 days 700 
after heterotopic transplantation. Quantification of collagen layer thickness (μm) 701 
by Sirius red staining with and without polarized light filter (A+B, by ANOVA 702 
post-hoc Newman-Keuls multiple comparison test). Area of collagen deposition 703 
stained by Sirius Red and quantified using ImageJ under transmission light (C). 704 
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Representative pictures of collagen deposition visualized using Sirius red 705 
staining with and without polarized light (D). 706 
Figure 6: HYP content is decreased in grafts from Ogr1-/- donor mice 707 
explanted at day 7 after heterotopic transplantation compared to grafts from 708 
WT donor mice (by unpaired t-test). 709 
Supplementary figure 1: mRNA expression of fibrosis markers COL1A1, 710 
COL3A1, ACTA2, TGFB1 (A) and G-protein coupled receptors (GPRs) OGR1 711 
(GPR68), TDAG8 (GPR65) GPR4 and GPR132 (B) in non-fibrotic terminal 712 
ileum of patients with CD compared to non-cancer affected terminal ileum of 713 
patients with colonic adenocarcinoma (by Mann-Whitney U test rank test). 714 
Supplementary figure 2: GPR68 (OGR1), GPR65 (TDAG8), GPR132 and 715 
GPR4 mRNA expression in whole human intestinal mucosa is significantly 716 
increased compared to the expression in isolated intestinal crypts (by Kruskal-717 
Wallis post-hoc Dunn’s multiple comparison). 718 
Supplementary figure 3: Hsp90b1 mRNA expression is significantly 719 
decreased in Ogr1-/- grafts 7 days after heterotopic transplantation compared 720 
to day 0 (***p < 0.001 by ANOVA post-hoc Newman-Keuls multiple 721 
comparison test).  722 
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TABLES 723 
Table 1 
 
OGR1 
(GPR68) 
TDAG8 
(GPR65) 
GPR4 GPR132 
COL1A1 
Correlation 
Coefficient 
0.791 0.783 0.887 0.036 
P value 0.000 0.000 0.000 0.880 
COL3A1 
Correlation 
Coefficient 
0.779 0.764 0.905 0.006 
P value 0.000 0.000 0.000 0.980 
ACTA2 
Correlation 
Coefficient 
0.689 0.782 0.880 -0.120 
P value 0.001 0.000 0.000 0.613 
TGFB1 
Correlation 
Coefficient 
0.850 0.913 0.820 0.137 
P value 0.000 0.000 0.000 0.565 
OGR1 
(GPR68) 
Correlation 
Coefficient 
 0.898 0.758 0.869 
P value  0.000 0.000 0.000 
Table 1: Spearman correlation between markers for fibrosis and G-protein 724 
coupled receptors (GPRs).  725 
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SUPPLEMENTARY TABLES 726 
 CD (n=8) Control (n=4) 
General   
Gender, % female 8 (100%) 2 (50%) 
Age at sample, years (mean, min-max) 34.7 (21.1-65.6) 73.1 (69.1-78.2) 
Disease duration, years, (mean, min-max) 8.6 (0.8-35.2) NA 
Montreal age at diagnosis (n (%))   
17-40 years (A2) 8 (100%) NA 
Montreal disease behavior (n (%))   
Stricturing disease (B2) 8 (100%) NA 
Disease location (n (%))   
Terminal ileum (L1) 4 (50%) NA 
Ileocolon (L3) 4 (50%)  
C-reactive protein before operation (n (%))   
C-reactive protein >5mg/L 2 (25%) NA 
C-reactive protein <5mg/L 4 (50%)  
Missing 2 (25%)  
Clinical disease activity before operation (n (%))   
Disease in remission 0 (0%) NA 
Mild disease 1 (12.5%)  
Moderate disease 4 (50%)  
Severe disease 3 (37.5%)  
Medication (n (%))   
No medication 1 (12.5%) NA 
Corticosteroids 1 (12.5%) 
Azathioprine/6-mercaptopurine 2 (25%) 
Azathioprine/6-mercaptopurine + corticosteroids 2 (25%) 
Anti-TNF 1 (12.5%) 
Anti-IL12/23 + corticosteroids 1 (12.5%) 
Supplementary Table 1: Characteristics of patients with CD and control 727 
patients. CD: Crohn’s disease, NA: Not applicable   728 
S Hutter et al.   Decreased fibrogenesis upon OGR1 depletion       36 
___________________________________________________________________________ 
 
Gene Full name 
Taqman expression 
ID 
Human 
GPR68 Ovarian cancer G-protein coupled receptor-1  Hs00268858_s1 
GPR65 T cell death-associated gene 8  Hs00269247_s1 
GPR4  G-protein coupled receptor 4 Hs00270999_s1 
GPR132  G-protein coupled receptor 132 Hs01871869_s1  
COL1A1 Pro-collagen type III alpha 1 Hs00164004_m1 
COL3A1 Pro-collagen type I alpha 1 Hs00943809_m1 
ACTA2 α-smooth muscle actin  Hs00426835_g1 
TGFB1 Transforming growth factor beta 1  Hs00998133_m1 
HPRT Hypoxanthine phosphoribosyltransferase 1 4326321E 
ACTB Beta-actin  4310881E 
GAPDH Glyceraldehyde-3-phosphate dehydrogenase  4326317E 
Murine 
Gpr68 Ovarian cancer G-protein coupled receptor-1  Mm00558545_s1 
Gpr65 T cell death-associated gene 8  Mm00433695_m1 
Tgfb1  Transforming growth factor beta 1  Mm01178820_m1 
Vim Vimentin Mm01333430_m1 
Hsp90b1 Heat shock protein 90, beta (Grp94) member 1 Mm00441926_m1 
Ctgf Connective tissue growth factor  Mm01192933_g1 
Col3a1 Pro-collagen type III alpha 1 Mm01254476_m1 
Gapdh Glyceraldehyde-3-phosphate dehydrogenase  4352339E 
Supplementary Table 2: Taqman gene expression assays 729 
  730 
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Figure 2 744 
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Figure 3 753 
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Figure 4 786 
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Figure 5 812 
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